Get started
AXSOME THERAPEUTICS INCAXSOME THERAPEUTICS INCAXSOME THERAPEUTICS INC

AXSOME THERAPEUTICS INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast

1AXSM chart


Full chart

1AXSM upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.89 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−5.80 EUR
Net income (FY)
‪−277.44 M‬ EUR
Revenue (FY)
‪372.57 M‬ EUR
Shares float
‪40.45 M‬
Beta (1Y)
1.05

Employees


Employees (FY)
683
Change (1Y)
+138 +25.32%
Revenue / Employee (1Y)
‪545.49 K‬ EUR
Net income / Employee (1Y)
‪−406.21 K‬ EUR

About Axsome Therapeutics, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Herriott Tabuteau
Website
axsome.com
Headquarters
New York
Founded
2012
FIGI
BBG01TNWGK98
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1AXSM news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Check out other big names from the same industry as 1AXSM.

Frequently Asked Questions


The current price of 1AXSM is 99.74 EUR — it has increased by 1.73% in the past 24 hours. Watch AXSOME THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange AXSOME THERAPEUTICS INC stocks are traded under the ticker 1AXSM.
1AXSM stock has risen by 3.31% compared to the previous week, the month change is a 3.31% rise, over the last year AXSOME THERAPEUTICS INC has showed a 3.31% increase.
We've gathered analysts' opinions on AXSOME THERAPEUTICS INC future price: according to them, 1AXSM price has a max estimate of 186.05 EUR and a min estimate of 126.69 EUR. Watch 1AXSM chart and read a more detailed AXSOME THERAPEUTICS INC stock forecast: see what analysts think of AXSOME THERAPEUTICS INC and suggest that you do with its stocks.
1AXSM reached its all-time high on May 2, 2025 with the price of 99.74 EUR, and its all-time low was 92.26 EUR and was reached on Apr 25, 2025. View more price dynamics on 1AXSM chart.
See other stocks reaching their highest and lowest prices.
1AXSM stock is 1.70% volatile and has beta coefficient of 1.05. Track AXSOME THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is AXSOME THERAPEUTICS INC there?
Yes, you can track AXSOME THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
AXSOME THERAPEUTICS INC is going to release the next earnings report on May 5, 2025. Keep track of upcoming events with our Earnings Calendar.
1AXSM earnings for the last quarter are −1.49 EUR per share, whereas the estimation was −0.97 EUR resulting in a −53.85% surprise. The estimated earnings for the next quarter are −1.25 EUR per share. See more details about AXSOME THERAPEUTICS INC earnings.
AXSOME THERAPEUTICS INC revenue for the last quarter amounts to ‪114.73 M‬ EUR, despite the estimated figure of ‪114.05 M‬ EUR. In the next quarter, revenue is expected to reach ‪110.14 M‬ EUR.
1AXSM net income for the last quarter is ‪−72.36 M‬ EUR, while the quarter before that showed ‪−58.02 M‬ EUR of net income which accounts for −24.72% change. Track more AXSOME THERAPEUTICS INC financial stats to get the full picture.
No, 1AXSM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 4, 2025, the company has 683 employees. See our rating of the largest employees — is AXSOME THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AXSOME THERAPEUTICS INC EBITDA is ‪−236.30 M‬ EUR, and current EBITDA margin is −63.39%. See more stats in AXSOME THERAPEUTICS INC financial statements.
Like other stocks, 1AXSM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AXSOME THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.